SportX Rebrands To SX.Bet Amid Roadmap Update
Toronto, Ontario–(Newsfile Corp. – April 29, 2022) – The widespread crypto adoption, observed in the…
Year: 2022
Gelesis’ Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species Associated with Gut Health and Weight Loss, in New Study
New pre-clinical data presented today at the World of Microbiome Conference suggest adding superabsorbent hydrogel…
Novo Nordisk’s sales increased by 24% in Danish kroner and by 18% at constant exchange rates to DKK 42.0 billion in the first three months of 2022
Financial report for the period 1 January 2022 to 31 March 2022 …
Orphazyme announces update on in-court restructuring proceedings
Orphazyme A/S in restructuringCompany announcementNo. 23/2022Inside information www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, April 29, 2022…
Novo Nordisk’s sales increased by 24% in Danish kroner and by 18% at constant exchange rates to DKK 42.0 billion in the first three months of 2022
Financial report for the period 1 January 2022 to 31 March 2022 Operating profit increased…
Letter to shareholders from CLINUVEL’s CEO
LONDON, April 29, 2022 (GLOBE NEWSWIRE) — Dear shareholders, friends, Both from…
Santhera will Publish its 2021 Annual Report by June 3, 2022, and Hold its Annual General Meeting on June 29, 2022
Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, April 29, 2022 — Santhera Pharmaceuticals…
New three-year data for Roche’s Evrysdi (risdiplam) show long-term improvements in survival and motor milestones in babies with Type 1 spinal muscular atrophy (SMA)
91% of infants treated with Evrysdi in the FIREFISH study were still alive at three…
Bone Therapeutics announces 2021 full year results
REGULATED INFORMATION Strategic focus revised and fully focused on achieving topline results of the ALLOB…
CNERGENZ Berhad launches Prospectus for ACE Market IPO
KUALA LUMPUR, Apr 29, 2022 – (ACN Newswire) – Cnergenz Berhad (CNERGENZ), an established electronics…
EDX Events Presents DX Leaders Malaysia 2022
KUALA LUMPUR, Apr 29, 2022 – (ACN Newswire) – EDX Events presents virtual DX Leaders…
HilleVax Announces Pricing of Upsized Initial Public Offering
BOSTON, April 28, 2022 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company…
Year-End Review: DENSO Advances its Two Great Causes, Green and Peace of Mind
KARIYA, JAPAN, Apr 29, 2022 – (JCN Newswire) – DENSO, a leading mobility supplier, today…
DENSO Announces Financial Results
KARIYA, JAPAN, Apr 29, 2022 – (JCN Newswire) – DENSO, a leading mobility supplier, today…
Strategy Analytics: Samsung Hits Highest Global Smartphone Market Share in Five Years in Q1 2022
BOSTON–(BUSINESS WIRE)–#Brands—According to new research from Strategy Analytics, global smartphone shipments fell -11% YoY to…
Cleantek Industries Inc. Announces 2021 Results and Provides Operational Update
Calgary, Alberta–(Newsfile Corp. – April 28, 2022) – Cleantek Industries Inc. (TSXV: CTEK) (“Cleantek” or…
Wintermar Offshore Marine Reports 1Q2022 Results; Total revenue up 3%
JAKARTA, Apr 29, 2022 – (ACN Newswire) – Wintermar Offshore Marine (WINS:JK) has announced results…
El Salvador Talks Crypto with Policy Makers in Washington
Washington, D.C., Apr 29, 2022 – (ACN Newswire) – On May 26, 2022, Ambassador Milena…
U.S. Food and Drug Administration Approves Camzyos™ (mavacamten) for the Treatment of Adults With Symptomatic New York Heart Association Class II-III Obstructive Hypertrophic Cardiomyopathy (HCM) to Improve Functional Capacity and Symptoms
Camzyos is the first and only FDA-approved cardiac myosin inhibitor that specifically targets the source…
VICI Properties Inc. Announces Final Results and Settlement of Exchange Offers
NEW YORK–(BUSINESS WIRE)–VICI Properties Inc. (NYSE: VICI) (the “Company”) announced today the expiration and final…